Clinical Trial Update: Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial of formoterol-beclomethasone in bronchiectasis terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• formoterol/beclomethasone (formoterol/beclomethasone)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Bronchiectasis | Phase 3 | Status: TERMINATED